Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

MicroRNA Biomarkers in IBD-Differential Diagnosis and Prediction of Colitis-Associated Cancer

Research output: Contribution to journalReviewResearchpeer-review

DOI

  1. Gastrin and the moderate hypergastrinemias

    Research output: Contribution to journalReviewResearchpeer-review

  2. Osteosarcoma and Metastasis Associated Bone Degradation-A Tale of Osteoclast and Malignant Cell Cooperativity

    Research output: Contribution to journalReviewResearchpeer-review

  3. HDL cholesterol and non-cardiovascular disease: a narrative review

    Research output: Contribution to journalReviewResearchpeer-review

  4. The Role of Leptin in Fetal Growth during Pre-Eclampsia

    Research output: Contribution to journalReviewResearchpeer-review

  1. Mucosal microRNAs relate to age and severity of disease in ulcerative colitis

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Noncoding RNA (ncRNA) Profile Association with Patient Outcome in Epithelial Ovarian Cancer Cases

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Ovarian and Breast Cancer Risks Associated With Pathogenic Variants in RAD51C and RAD51D

    Research output: Contribution to journalJournal articleResearchpeer-review

View graph of relations

Inflammatory bowel disease (IBD) includes Crohn's disease (CD) and ulcerative colitis (UC). These are chronic autoimmune diseases of unknown etiology affecting the gastrointestinal tract. The IBD population includes a heterogeneous group of patients with varying disease courses requiring personalized treatment protocols. The complexity of the disease often delays the diagnosis and the initiation of appropriate treatments. In a subset of patients, IBD leads to colitis-associated cancer (CAC). MicroRNAs are single-stranded regulatory noncoding RNAs of 18 to 22 nucleotides with putative roles in the pathogenesis of IBD and colorectal cancer. They have been explored as biomarkers and therapeutic targets. Both tissue-derived and circulating microRNAs have emerged as promising biomarkers in the differential diagnosis and in the prognosis of disease severity of IBD as well as predictive biomarkers in drug resistance. In addition, knowledge of the cellular localization of differentially expressed microRNAs is a prerequisite for deciphering the biological role of these important epigenetic regulators and the cellular localization may even contribute to an alternative repertoire of biomarkers. In this review, we discuss findings based on RT-qPCR, microarray profiling, next generation sequencing and in situ hybridization of microRNA biomarkers identified in the circulation and in tissue biopsies.

Original languageEnglish
Article number7893
JournalInternational Journal of Molecular Sciences
Volume21
Issue number21
Pages (from-to)1-19
Number of pages19
ISSN1661-6596
DOIs
Publication statusPublished - 24 Oct 2020

    Research areas

  • Biomarkers, Circulating miRNA, Colitis-associated cancer (CAC), Crohn’s disease (CD), Inflammatory bowel disease (IBD), MicroRNA (miRNA), Ulcerative colitis (UC), Crohn&#8217, microRNA (miRNA), biomarkers, circulating miRNA, inflammatory bowel disease (IBD), s disease (CD), ulcerative colitis (UC), colitis-associated cancer (CAC)

ID: 61116188